Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting
...d noncompetitive environment. Key topics will include:
-- Advancements in drug discovery and development and the importance of clinical trials; -- aztreonam
lysine for inhalation as a potential new CF therapy; -- Quality improvement and patient outcomes; -- The importance of newborn screening; and -- Se...
Aztreonam in Medical Technology
PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation
MONTEREY, Calif., Nov. 26 /PRNewswire/ -- PARI Pharma's eFlow
electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent New
Drug Application (NDA) submittal to the U.S. Food and Drug Administration
(FDA) for marketing approval of aztreonam
lysine for inhalation (75 mg
three times d...
Gilead Announces Achievement of Primary Efficacy Endpoint in Second
Phase III Study of Aztreonam Lysine for Inhalation in Patients With
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 29, 2007 - Gilead
Sciences, Inc. (Nasdaq:GILD) today announced that its Phase III
AIR-CF1 (CP-AI-007) study of aztreonam
lysine for inhalation for
the treatment of people with cystic fibrosis (CF) who have
pulmonary Pseudomonas aeruginosa (P. aeruginosa) me...
Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
...c mean of the MIC in levofloxacin treated isolates increased less than two fold under anaerobic conditions, whereas tobramycin, amikacin and aztreonam
treated isolates increased 4-7 fold under anaerobic conditions. This implies that MP-376 may retain its potency in anaerobic environments i...
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
...ed patients had a clinical cure
rate of 91.6% compared to a vancomycin plus aztreonam
clinical cure rate of
92.7% at test-of-cure (TOC) visit in the clinically e...d a microbiological eradication rate of 92.4% compared to a
vancomycin plus aztreonam
rate of 93.6% for all pathogens when used as
treatment for cSSSI. The cefta...
Promising Cystic Fibrosis Compound on Track for Development
...e of Corus Pharmaceutical Company
last year, acquired the rights to develop aztreonam
lysine as an inhalation
product to treat Pseudomonas aeruginosa infections. The company has said it
will submit its new drug application (NDA) for aztreonam
lysine to the FDA
by the end of 2007. In the meantime, Gilead recently anno...
Gilead Announces Presentation of Positive Phase III Data on
Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
... results of its Phase III
AIR-CF2 study evaluating aztreonam
lysine for inhalation, an
antibiotic, in patients ...inosa). In the study, a
28-day treatment course of aztreonam
lysine significantly improved
the time to need for...ety and efficacy of a 28-day treatment
course with aztreonam
lysine for inhalation following a 28-day
Aztreonam in Medical Products
Antibiotic Level, Aztreonam
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Aztreonam in Biological Technology
Aztreonam in Biological Dictionary
...icians. ... When is it okay for me to take antibiotics ? ... Information about antibiotic in the free online English dictionary and ... Azactam, aztreonam
- an antibiotic (trade name Azactam) used against severe ... Antibiotic overuse is discussed. Dr. Greene explains when antibiotics should or ...